China NMPA Drug Inspection - Bozhou Boyaotang Pharmaceutical Co., Ltd. - Traditional Chinese medicine decoction pieces, including Bupleurum root and Typha pollen.
China NMPA drug inspection for Bozhou Boyaotang Pharmaceutical Co., Ltd. published November 18, 2019. Drug: Traditional Chinese medicine decoction pieces, including Bupleurum root and Typha pollen.. The Shandong Provincial Food and Drug Administration issued an announcement in May 2017, later publicized in November 20
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Bozhou Boyaotang Pharmaceutical Co., Ltd. published November 18, 2019. Drug: Traditional Chinese medicine decoction pieces, including Bupleurum root and Typha pollen.. The Shandong Provincial Food and Drug Administration issued an announcement in May 2017, later publicized in November 20
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox